mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |